We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Saturday
May 13
15:15 - 16:15
Business Suite 1-2
Breast
Dorota Gabrys, Poland
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.
Poster Discussion
Clinical
One week hypofractionated breast radiotherapy acute toxicity with SIB and regional nodal irradiation
Guillermo Potdevin-Stein, Spain
PD-0230
Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer
Dieuwke Mink van der Molen, The Netherlands
PD-0231
Skin Dose Predictors of Early-Late Reactions after Whole Breast RT in a Single-Center Large-Cohort
Alessandro Cicchetti, Italy
PD-0232
One-Week External Beam Partial Breast Irradiation: Survival and Toxicity Outcomes
Riccardo Ray Colciago, Italy
PD-0233
Single-fraction stereotactic radiotherapy for Partial Breast Irradiation using the Gammapod system
Marco Trovo, Italy
PD-0234
Variation in incidental dose to the axilla in patients treated with whole breast radiotherapy alone
Fiona Wilson, United Kingdom
PD-0235
Patterns of recurrence in breast cancer patients after nipple-sparing and skin-sparing mastectomy
Leticia Alvarado Alvarado, Guatemala
PD-0236
Intrafractional dose coverage of the internal mammary nodes in high-risk breast cancer patients
Anders W. Mølby Nielsen, Denmark
PD-0237
OIS-triggered PROMs for large-scale symptom tracking: Experience after 1000 patients
Andreas Renner, Austria
PD-0238
Why is pain poorly managed in breast cancer patients? A multicenter analysis on 2104 patients
Costanza Maria Donati, Italy
PD-0239
Ten-year outcomes of SBRT for oligometastatic breast cancer (OMBC): does synchronous OMBC benefit?
Sukhdeep Kaur Nagpal, United Kingdom
PD-0240
Differences in metastatic pattern between 18F-FDG-PET/CT and "CT only" in OMD breast cancer
Sophie Pfeiffer, Germany
PD-0241